Role of carboxyl terminus of μ- and δ-opioid receptor in agonist -induced down-regulation

Molecular Brain Research

Volumn 54, Issue 1, 1998, Pages 24-34

  Afify, Elham A ^a   Law, Ping Y ^a   Riedl, Maureen ^a   Elde, Robert ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

and opioid receptor; Carboxyl terminus; Down regulation; Etorphine; Immunofluorescence

Indexed keywords

ADENYLATE CYCLASE; DELTA OPIATE RECEPTOR; ETORPHINE; HEMAGGLUTININ; MU OPIATE RECEPTOR; OPIATE AGONIST;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; DOWN REGULATION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREACTIVITY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BINDING, COMPETITIVE; DOWN-REGULATION; MICE; NEUROBLASTOMA; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031886497     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00315-X     Document Type: Article

References (36)

1. Arvidsson U., Riedl M., Chakrabarti S., Lee J.-H., Nakano A., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., Elde R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:1995;3328-3341.
2. 2-adrenergic receptor sequestration. J. Biol. Chem. 269:1994;2790-2795.
3. Benovic J.L., Pike L.J., Cerione R.A., Staniszewski C., Yoshimasa T., Codina J., Caron M.G., Lefkowitz R.J. Phosphorylation of the mammalian β-adrenergic receptor by cyclic AMP-dependent protein kinase. J. Biol. Chem. 260:1985;7094-7101.
4. Chakrabarti S., Law P.Y., Loh H.H. Neuroblastoma Neuro 2A cells stably expressing a cloned μ-opioid receptor: a specific cellular model to study acute and chronic effects of morphine. Mol. Brain Res. 30:1995;269-278.
5. S. Chakraberti, W. Yang, P.-Y. Law, H. Loh, The μ-opioid receptor down-regulates differently from the δ-opioid receptor: requirement of a high affinity receptor-G-protein complex formation, Mol. Pharmacol., in press (1997).
6. 424 residues in the carboxyl terminus are critical for the internalization of the rat neurotensin receptor. J. Biol. Chem. 270:1995;2439-2442.
7. Chen Y., Okayama H. Calcium phosphate-mediate gene transfer: a high efficient transfection system for stable transforming cells with plasmid DNA. Mol. Cell Biol. 7:1987;2745-2752.
8. i) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzyme reaction. Biochem. Pharmacol. 22:1973;3099-3108.
9. 353, located within the COOH-terminal of the δ-opioid receptor, is involved in receptor down-regulation. J. Biol. Chem. 271:1996;4073-4076.
10. Doss R.C., Perkins J.P., Harden T.K. Recovery of β-adrenergic receptors following long term exposure of astrocytoma cells to catecholamine. J. Biol. Chem. 256:1981;12281-12286.
11. Ferguson S.C., Downey W.E., Colapietro A.-M., Barak L.S., Menard L., Caron M.G. Role of β-arrestin in mediating agonist-promoted G-protein-coupled receptor internalization. Science. 271:1996;363-366.
12. Gaudriault G., Nouel D., Farra C., Beaudet A., Vincent J. Receptor-induced internalization of selective peptidic μ- and δ-opioid ligands. J. Biol. Chem. 272:1997;2880-2888.
13. Gurevich V.V., Dion S.B., Onorato J.J., Ptasienski J., Kim C.M., Sterne-Marr R., Hosey M.M., Benovic J.L. Arrestin interactions with G-protein-coupled receptor. J. Biol. Chem. 270:1995;720-773.
14. Hausdorff W.P., Caron M.G., Lefkowitz R.J. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4:1990;2881-2889.
15. Hausdorff W.P., Campbell P.T., Ostrowski J., Yu S.S., Caron M.G., Lefkowitz R.J. A small region of the β-adrenergic receptor is selectively involved in its rapid regulation. Proc. Natl. Acad. Sci. USA. 88:1991;2979-2983.
16. Hertel C., Nunnally M.H., Wong S.K.-F., Murphy E.A., Ross E.M., Perkins J.P. A truncation mutation in the avian β-adrenergic receptor causes agonist-induced internalization and GTP-sensitive agonist binding characteristic of mammalian receptor. J. Biol. Chem. 265:1990;17988-17994.
17. Huang Z., Chen Y., Nissenson R.A. The cytoplasmic terminus of the G-protein-coupled receptor for parathyroid hormone and parathyroid hormone-related protein contains positive and negative signals for endocytosis. J. Biol. Chem. 270:1995;151-156.
18. Law P.Y., Koehler J.E., Loh H.H. Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma X glioma NG108-15 cell lines. Mol. Pharmacol. 21:1982;483-491.
19. Law P.Y., Hom D.S., Loh H.H. Down-regulation of opiate receptor in neuroblastoma X glioma NG108-15 hybrid cells. J. Biol. Chem. 259:1983;4096-4104.
20. Law P.Y., Hom D.S., Loh H.H. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG 108-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24:1983;413-424.
21. Lohse M.J., Andexinger S., Pitcher J., Trukawinski S., Codina J., Faure J.-P., Caron M.G., Lefkowitz R.J. Receptor-specific desensitization with purified proteins. J. Biol. Chem. 267:1992;8558-8564.
22. Milligan G. Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications. Trends Pharmacol. Sci. 14:1982;413-418.
23. Morishima I., Thompson W.J., Robinson G.A., Strada J.J. Loss and restoration of sensitivity to epinephrine in cultured BHK cells: effect of inhibitors of RNA and protein synthesis. Mol. Pharmacol. 18:1980;370-378.
24. Moro O., Lameh J., Wolfgang S. Serine- and threonine-rich domain regulates internalization of muscarinic cholinergic receptors. J. Biol. Chem. 268:1993;6862-6865.
25. Pearse B.M. Receptors compete for adaptors found in plasma membrane coated pits. EMBO J. 7:1988;3331-3336.
26. Prado G.N., Suzuki H., Wilkinson N., Cousins B., Navarro J. Role of the C-terminus of the interleukin 8 receptor in signal transduction and internalization. J. Biol. Chem. 271:1996;19186-19190.
27. Prather P.L., Tsai A.W., Law P.Y. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SH-SY5Y cells. J. Pharmacol. Exp. Ther. 270:1994;177-184.
28. Puttfarcken P.S., Werling L.L., Cox B.M. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membrane: a useful model for the study of tolerance at μ-opioid receptors. Mol. Pharmacol. 33:1988;520-527.
29. Sibley D.R., Benovic J.L., Caron M.G., Lefkowitz R.J. Regulation of transmembrane signalling by receptor phosphorylation. Cell. 48:1987;913-922.
30. Tao P.-L., Law P.Y., Loh H.H. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J. Pharmacol. Exp. Ther. 240:1987;809-816.
31. 5] enkephalin treatment. Brain Res. 462:1988;313-320.
32. Thomas W.G., Thekkumkara T.J., Motel T.J., Baker K.M. Stable expression of a truncated AT 1A receptor in CHO-K1 cells. J. Biol. Chem. 270:1995;207-213.
33. Vachon L., Costa T., Herz A. Opioid receptor desensitization in NG 108-15 cells. Biochem. Pharmacol. 36:1987;2889-2897.
34. 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J. Biol. Chem. 267:1992;3530-3538.
35. White A.A., Kar D.B. Improved two-step method for the assay of adenylate and guanylate cyclase. Anal. Biochem. 85:1978;451-460.
36. Zhang J., Ferguson S.G., Barak L.S., Menard L., Caron M.G. Dynamin and β-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J. Biol. Chem. 271:1996;18302-18305.